View in EDS HTML Full Text PDF Full Text

Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison.

Saved in:
Bibliographic Details
Title: Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison.
Authors: Bhatt, Surya P.1 (AUTHOR), Freemantle, Nick2 (AUTHOR), Soliman, Mena3 (AUTHOR), Heble, Jigna4 (AUTHOR), Cabon, Yann5 (AUTHOR), Mayen Herrera, Ernesto4 (AUTHOR), Yang, Joe3,6 (AUTHOR), Xu, Yingxin6 (AUTHOR) yingxin.xu@regeneron.com
Source: Pulmonary Therapy. Mar2026, Vol. 12 Issue 1, p201-217. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23641746
DOI:10.1007/s41030-025-00322-1